Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"

[unchecked revision]

Revision as of 23:54, 23 December 2023

Welcome!

For assignments, please see the "Author" column below (3rd column from left).
- If empty (no name is present), please volunteer to create content for that disease!
- If "PENDING" is present, the original author of that disease page is currently being contacted about revising the content.
To volunteer, please [Contact us] with your page of interest.
Note - "NEW (No Prior)" in the 4th edition columns means either the disease is a new entity in the 5th edition or the disease was present in the 4th edition without content added.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
Disease (5th Edition)	Page Type	Author (5th Edition) (Note: please indicate trainees in parentheses)	Date Assigned to Author (5th Edition)	Content Status (5th Edition)(Pending or Complete)	Date Completed by Author (5th Edition)	Associate Editor	Notes (5th Edition)	Correlated Prior Disease Name (4th Edition)	Correlated Prior Author (4th Edition)	Prior Content Status (4th Edition)(Pending or Complete)	Prior Date of Last Editor Review (4th Edition)	Prior Notes (4th Edition)
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
Clonal haematopoiesis	Disease					Fabiola Quintero-Rivera (FQR)		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Clonal cytopenias of undetermined significance	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Chronic myeloid leukaemia	Disease	PENDING				FQR		Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive	Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)	Complete	Date page was created
Chronic neutrophilic leukaemia	Disease	PENDING				FQR		Chronic Neutrophilic Leukemia (CNL)	Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally	Complete	Date page was created
Chronic eosinophilic leukaemia	Disease	PENDING				FQR		Chronic Eosinophilic Leukemia, Not Otherwise Specified	Chelsea D. Kramish; Daynna J.Wolff	complete/pending faculty review
Polycythaemia vera	Disease	PENDING				FQR		Polycythemia Vera (PV)	Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center	Complete
Essential thrombocythaemia	Disease	PENDING				FQR		Essential Thrombocythemia (ET)	Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN	Complete
Primary myelofibrosis	Disease	PENDING				FQR		Primary Myelofibrosis (PMF)	T. Niroshi Senaratne, UCLA	Complete	8/4/2020 before submission
Juvenile myelomonocytic leukaemia	Disease	PENDING				FQR		Juvenile Myelomonocytic Leukemia (JMML)	Sarah Rapisardo, PhD, FACMG \| Assistant Professor, Pathology Associate Director \| Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories	PENDING importing content and reference formatting		FQR has emailed SR several times, last 4/20/22
Myeloproliferative neoplasm, NOS	Disease	PENDING				FQR		Myeloproliferative Neoplasm (MPN), Unclassifiable	Thomas Lee, MD, PhD, University of California, Los Angeles	Complete
Cutaneous mastocytosis	Disease	PENDING				FQR		Cutaneous Mastocytosis	S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD	Complete
Systemic mastocytosis	Disease	PENDING				FQR		Systemic Mastocytosis	Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University	Complete
Mast cell sarcoma	Disease	PENDING				FQR		Mast Cell Sarcoma	Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL	Complete
Myelodysplastic neoplasm with low blasts and 5q deletion	Disease	PENDING				FQR		Myelodysplastic Syndrome (MDS) with Isolated del(5q)	Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG	Complete
Myelodysplastic neoplasm with low blasts and SF3B1 mutation	Disease	PENDING				FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with biallelic TP53 inactivation	Disease	Eric McGinnis (assigned to new 5th edition page - FQR is this reviewed?)				FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with low blasts	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm, hypoplastic	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with increased blasts	Disease	PENDING				FQR		Myelodysplastic Syndrome (MDS) with Excess Blasts	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with low blasts	Disease	PENDING				FQR		Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with increased blasts	Disease	PENDING				FQR		Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Chronic myelomonocytic leukaemia	Disease	PENDING				FQR		Chronic Myelomonocytic Leukemia (CMML)	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with neutrophilia	Disease	PENDING				FQR		Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis	Disease	PENDING				FQR		Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)	Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine	Complete	Date page was created
Myelodysplastic/myeloproliferative neoplasm, NOS	Disease	PENDING				FQR		Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable	Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia	Complete
Acute promyelocytic leukaemia with PML::RARA fusion	Disease	PENDING				Jennelle Hodge (JH)/ Malini Sathanoori (MS)		Acute Promyelocytic Leukemia (APL) with PML-RARA	Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	04/26/2021-MS (re-review)
Acute myeloid leukaemia with CBFB::MYH11 fusion	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with DEK::NUP214 fusion	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214	Jennelle C. Hodge, PhD, FACMG	Complete	02/24/2021-MS (re-review)
Acute myeloid leukaemia with RBM15::MRTFA fusion	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with BCR::ABL1 fusion	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with BCR-ABL1	Kay Weng Choy MBBS, Monash Medical Centre	Complete
Acute myeloid leukaemia with KMT2A rearrangement	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3	Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with MECOM rearrangement	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM	Gordana Raca MD PhD, University of Southern California, Los Angeles	Complete		Need permission for figure? Update WHO?
Acute myeloid leukaemia with NUP98 rearrangement	Disease	Eric McGinnis, MD	12/20/23			JH_MS		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with NPM1 mutation	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with Mutated NPM1	Xinjie Xu, PhD, FACMG	Complete		Add WHO reference
Acute myeloid leukaemia with CEBPA mutation	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA	Paul Defazio, MSc, Monash Health	Complete
Acute myeloid leukaemia, myelodysplasia-related	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute myeloid leukaemia with other defined genetic alterations	Disease					JH_MS		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with minimal differentiation	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with Minimal Differentiation	Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine	Complete
Acute myeloid leukaemia without maturation	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) without Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with maturation	Disease	PENDING				JH_MS		Acute Myeloid Leukemia (AML) with Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute basophilic leukaemia	Disease	PENDING				JH_MS		Acute Basophilic Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute myelomonocytic leukaemia	Disease	PENDING				JH_MS		Acute Myelomonocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute monocytic leukaemia	Disease	PENDING				JH_MS		Acute Monoblastic and Monocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute erythroid leukaemia	Disease	PENDING				JH_MS		Pure Erythroid Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute megakaryoblastic leukaemia	Disease	PENDING				JH_MS		Acute Megakaryoblastic Leukemia (AMKL)	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Myeloid sarcoma	Disease	PENDING				JH_MS		Myeloid Sarcoma	Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine	Complete
RESOLVE 4th edition AML-Related NON-WHO entities content	Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6	ISSUE- FIX Resolve Non-WHO entities
Myeloid neoplasm post cytotoxic therapy	Disease	PENDING				JH_MS		Therapy-Related Myeloid Neoplasms	Shawn A. Silver, DO, Shashi Shetty, Ph.D.	Complete		Check reference format
Myeloid neoplasms associated with germline predisposition	Disease	PENDING				JH_MS		Multiple pages including overview page (Myeloid Neoplasms with Germline Predisposition - Compendium of Cancer Genome Aberrations (ccga.io)) and 6 disease pages ( HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation, HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation, HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation, HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation, HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation, HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation)	See links from instructions on the 5th edition page	Complete	Most were re-reviewed by MS on 03/02/2021	For page Acute Myeloid Leukaemia with Germline CEBPA Mutation - Note by MS of "Review completed, awaiting some clarification from JH - 07/04/2022"
Myeloid proliferations associated with Down syndrome	Disease	PENDING				JH_MS		MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome	Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO	Complete (all three pages)
Myeloid/lymphoid neoplasm with PDGFRA rearrangement	Disease	PENDING				FQR		Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement	Jay Alden, DO	Complete
Myeloid/lymphoid neoplasm with PDGFRB rearrangement	Disease	PENDING				FQR		Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement	Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD	Complete
Myeloid/lymphoid neoplasm with FGFR1 rearrangement	Disease	PENDING				FQR		Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement	Yanna Ding, MD PhD	Complete
Myeloid/lymphoid neoplasm with JAK2 rearrangement	Disease	ISSUE- FIX Resolve Non-WHO entities				FQR		Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff	Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff	Complete
Myeloid/lymphoid neoplasm with FLT3 rearrangement	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes	Disease					FQR		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion	Disease	PENDING				JH_MS		Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1	Tracy Tucker, PhD, FCCMG	Complete
Mixed-phenotype acute leukaemia with KMT2A rearrangement	Disease	PENDING				JH_MS		Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged	Tracy Tucker, PhD, FCCMG	Complete
Acute leukaemia of ambiguous lineage with other defined genetic alterations	Disease					JH_MS		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Mixed-phenotype acute leukaemia, B/myeloid	Disease	PENDING				JH_MS		Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified	Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD	Complete
Mixed-phenotype acute leukaemia, T/myeloid	Disease	PENDING				JH_MS		Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified	Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine	Complete
Mixed-phenotype acute leukaemia, rare types	Disease	PENDING				JH_MS		Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types	Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina	PENDING
Acute leukaemia of ambiguous lineage, NOS	Disease					JH_MS		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute undifferentiated leukaemia	Disease	PENDING				JH_MS		Acute Undifferentiated Leukemia	Amelia Nakanishi, MD and Shashi Shetty, PhD	Complete		Check reference format
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm	Disease					Greg Corboy (GC)		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Blastic plasmacytoid dendritic cell neoplasm	Disease	PENDING				GC		Blastic Plasmacytoid Dendritic Cell Neoplasm	Hao Liu, MD and Daynna J. Wolff, PhD	Complete		Previously within myeloid section under JH/MS editors
Langerhans cell histiocytosis	Disease	PENDING				GC		Langerhans Cell Histiocytosis	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland	Complete	5/19/2022	Date completed by author: 04/28/2022
Langerhans cell sarcoma	Disease	PENDING				GC		Langerhans Cell Sarcoma	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland	Complete	5/19/2022	Date completed by author: 04/28/2022
Indeterminate dendritic cell tumour	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Interdigitating dendritic cell sarcoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Juvenile xanthogranuloma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Erdheim-Chester disease	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Rosai-Dorfman Disease	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
ALK-positive histiocytosis	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Histiocytic sarcoma	Disease	PENDING				GC		Histiocytic Sarcoma	Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic	Complete	10/01/2021	Date completed by author: 10/01/2021
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Reactive B-cell rich lymphoid proliferations that can mimic lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
IgG4-related disease	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Unicentric Castleman disease	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Idiopathic multicentric Castleman disease	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
KSHV/HHV8-associated multicentric Castleman disease	Disease	PENDING				GC		Multicentric Castleman Disease	Sudha Arumugam, MD	Complete	01/24/2022	Date completed by author: 01/24/2022
B-lymphoblastic leukaemia/lymphoma	Disease	PENDING				Holli Drendel (HD)		B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified	Holli Drendel	PENDING
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG	PENDING
B-lymphoblastic leukaemia/lymphoma with hypodiploidy	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy	Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG	Complete
B-lymphoblastic leukaemia/lymphoma with iAMP21	Disease	Holli Drendel authoring - Complete? Looks like needs more editing of tables				HD		B-Lymphoblastic Leukemia/Lymphoma with iAMP21 [but was completed as a 5th edition page by Holli]	Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte	?Complete
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG	PENDING
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like	Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine	Complete
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged	Yassmine Akkari Nicolas Millan	PENDING
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion	Disease	PENDING				HD		B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion	Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma	PENDING
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features	Disease					HD		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO	PENDING
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion	Disease	PENDING				HD		B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO	PENDING
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion	Disease					HD		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations	Disease					HD		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
B-lymphoblastic leukaemia/lymphoma, NOS	Disease					HD		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
RESOLVE 4th edition ALL-Related NON-WHO entities content	B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)	ISSUE- FIX Resolve Non-WHO entities							ISSUE - FIX
Monoclonal B-cell lymphocytosis	Disease	PENDING				Shivani Golem (SG)		Monoclonal B-cell Lymphocytosis	Tsigab Bahta Hagos (trainee) / Shashirekha Shetty	PENDING		Assigned 12/19/2022 with completion date of 1/19/2023
Chronic lymphocytic leukaemia/small lymphocytic lymphoma	Disease	Jaime Nagy, PhD, University of Iowa Renee Eigsti, MD, Pathology Services of Kalamazoo Honey Reddi, PhD, Belay Diagnostics		Complete (Shivani, please confirm)		SG		Already converted to 5th edition	Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD
Hairy cell leukaemia	Disease	PENDING				SG		Hairy Cell Leukemia	Snehal Patel, MD, PhD	Complete
Splenic marginal zone lymphoma	Disease	PENDING				SG		Splenic Marginal Zone Lymphoma	Snehal Patel, MD, PhD	Complete
Splenic diffuse red pulp small B-cell lymphoma	Disease	PENDING				SG		Splenic Diffuse Red Pulp Small B-cell Lymphoma	Snehal Patel, MD, PhD	Complete
Splenic B-cell lymphoma/leukaemia with prominent nucleoli	Disease	PENDING				SG		Hairy Cell Leukemia Variant	Snehal Patel, MD, PhD	Complete
Lymphoplasmacytic lymphoma	Disease	PENDING				SG		(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia	(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)	Complete	4/12/2023 by FQR
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	Disease	PENDING				SG		Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)	Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG* Department of Pathology and Laboratory Medicine and *Pediatrics, School of Medicine, University of California Irvine (UCI)	Complete	4/12/23 by FQR
Primary cutaneous marginal zone lymphoma	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Nodal marginal zone lymphoma	Disease	PENDING				SG		Nodal Marginal Zone Lymphoma	Andrew Ly, DO and Shivani Golem, PhD, FACMG	Complete	5/28/2021
Paediatric nodal marginal zone lymphoma	Disease	PENDING				SG		Paediatric Nodal Marginal Zone Lymphoma	* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD	Complete	11/11/2020
In situ follicular B-cell neoplasm	Disease	Rachel D. Burnside, PhD, MBA, FACMGG	7/28/2023	Pending		SG		In Situ Follicular Neoplasia	Rachel D. Burnside, PhD, MBA, FACMGG	Pending
Follicular lymphoma	Disease	Rachel D. Burnside, PhD, MBA, FACMGG	7/28/2023	Pending		SG	Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity	(1) Follicular Lymphoma + (2) Testicular Follicular Lymphoma	(1 and 2) Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida	Pending
Paediatric-type follicular lymphoma	Disease	PENDING				SG		Paediatric-Type Follicular Lymphoma	Kathleen M. Schieffer, PhD Ruthann Pfau, PhD, FACMG	Complete	8/16/2020
Duodenal-type follicular lymphoma	Disease	Rachel D. Burnside, PhD, MBA, FACMGG	7/28/2023	Pending		SG		Duodenal-Type Follicular Lymphoma	No prior content
Primary cutaneous follicle centre lymphoma	Disease	PENDING				SG		Primary Cutaneous Follicle Centre Lymphoma	Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG	Complete	09/10/2022
In situ mantle cell neoplasm	Disease	PENDING				SG		In Situ Mantle Cell Neoplasia	Rina Kansal, MD; Versiti Blood Center of Wisconsin	Complete	7/26/2022
Mantle cell lymphoma	Disease	PENDING				SG		Mantle Cell Lymphoma	* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas	Pending		Target completion date 8/15/20
Leukaemic non-nodal mantle cell lymphoma	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Transformations of indolent B-cell lymphomas	Disease					SG	Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Diffuse large B-cell lymphoma, NOS	Disease	PENDING				GC		Diffuse Large B-cell Lymphoma, Not Otherwise Specified	Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center	Pending		Requested to update 14022022
T-cell/histiocyte-rich large B-cell lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements	Disease	PENDING				GC		High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements	Kate Berry, MBBS, BBus (Hons), Pathology Queensland	Complete	24/02/2022
ALK-positive large B-cell lymphoma	Disease	PENDING				GC		ALK-Positive Large B-cell Lymphoma	Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)	Pending		Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. FQR emailed Manando on 4/12/23
Large B-cell lymphoma with IRF4 rearrangement	Disease	PENDING				GC		Large B-cell Lymphoma with IRF4 Rearrangement	Afia Hasnain, MBBS, PhD	Complete	5/26/2021
High grade B-cell lymphoma with 11q aberrations	Disease	PENDING				GC		Burkitt-Like Lymphoma with 11q Aberration	Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina	Comlete	27/01/2022
Lymphomatoid granulomatosis	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
EBV-positive diffuse large B-cell lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Diffuse large B-cell lymphoma associated with chronic inflammation	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Fibrin-associated large B-cell lymphoma	Disease	PENDING				GC	Note: previously a subset DLBCL assoc with chronic inflam	Originally called Fibrin-Associated Diffuse Large B-cell Lymphoma; NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Fluid overload-associated large B-cell lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Plasmablastic lymphoma	Disease	PENDING				GC		Plasmablastic Lymphoma	Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)	Complete	28/03/2022
Primary large B-cell lymphoma of immune-privileged sites	Disease	PENDING				GC		(1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS	(1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital	(1) Pending + (2) Complete	(1) Not ready + (2) 03/28/22	For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022
Primary cutaneous diffuse large B-cell lymphoma, leg type	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Intravascular large B-cell lymphoma	Disease	PENDING				GC		Intravascular Large B-cell Lymphoma	Kate Berry, MBBS, BBus (Hons), Pathology Queensland, Greg Corboy	Complete	9/1/22	Emailed 28/3/2022 for progress update
Primary mediastinal large B-cell lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Mediastinal grey zone lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
High-grade B-cell lymphoma, NOS	Disease	PENDING				GC		High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)	Aiko Otsubo, PhD, Indiana University, Holli Drendel	Complete	16/11/2021
Burkitt lymphoma	Disease	PENDING				GC		Burkitt Lymphoma	Becky Leung, MBBS (Hons), BSc, Pathology Queensland	Complete	28/06/2021
Primary effusion lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
KSHV/HHV8-positive diffuse large B-cell lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
KSHV/HHV8-positive germinotropic lymphoproliferative disorder	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Hyperplasias arising in immune deficiency/dysregulation	Disease	FIX ISSUE! (on 5th edition page instructions say "encompassing non-destructive post-transplant lymphoproliferative disorders, among others")				GC
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation	Disease	FIX ISSUE! (on 5th edition page instructions say "This page was converted to the new template on 2023-12-07. The original page can be found at HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders. Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others)"				GC		Polymorphic Post-Transplant Lymphoproliferative Disorders	Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)	Completed	26/4/2022
EBV-positive mucocutaneous ulcer	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Lymphomas arising in immune deficiency / dysregulation	Disease	FIX ISSUE! (on 5th edition page instructions say "encompassing monomorphic PTLD, classic HL PTLD, lymphomas assoc with HIV infection, among others"				GC
Inborn error of immunity-associated lymphoid proliferations and lymphomas	Disease	FIX ISSUE! (on 5th edition page instructions say "Editor said this overview page is a match. [Immunodeficiency-Associated Lymphoproliferative Disorders] [Lymphoproliferative diseases associated with primary immune disorders]")				GC
Classic Hodgkin lymphoma	Disease	PENDING			Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma	GC		(1) Lymphocyte-Rich Classic Hodgkin Lymphoma + (2) Nodular Sclerosis Classic Hodgkin Lymphoma + (3) Mixed Cellularity Classic Hodgkin Lymphoma + (4) Lymphocyte-Depleted Classic Hodgkin Lymphoma	(1) Patricia V. Hernandez, M.D., Washington University School of Medicine and Holli Drendel + (2) Xiaolin Hu, PhD, Sema4 OpCo Inc. + (3 and 4) Patricia V. Hernandez	Pending + Completed (03/21/22)	Not completed for checking (1, 3 and 4) + 03/21/22 (2)
Nodular lymphocyte predominant Hodgkin lymphoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Cold agglutinin disease	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
IgM monoclonal gammopathy of undetermined significance	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Non-IgM monoclonal gammopathy of undetermined significance	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Monoclonal gammopathy of renal significance	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Immunoglobulin-related (AL) amyloidosis	Disease	PENDING				SG		Primary Amyloidosis	Heather E. Williams, PhD, MS, PgD, ErCLG	?PENDING
Monoclonal immunoglobulin deposition disease	Disease	PENDING				SG		Light Chain and Heavy Chain Deposition Disease	Chen Yang, MD, PhD, University of Michigan	Complete	10/15/2022
Mu heavy chain disease	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Gamma heavy chain disease	Disease	PENDING				SG		Gamma Heavy Chain Disease	Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA	Complete	5/26/2021
Alpha heavy chain disease	Disease					SG		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Plasmacytoma	Disease	PENDING			author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)	SG		NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Plasma cell myeloma / multiple myeloma	Disease	PENDING			Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page	SG		(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants	(1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG	Pending
Plasma cell neoplasms with associated paraneoplastic syndrome	Disease	PENDING			Note: author needs to include POEMS, TEMPI, and look for AESOP content	SG		(1) POEMS Syndrome + (2) TEMPI Syndrome	(1 and 2) Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD	?PENDING
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Kikuchi-Fujimoto disease	Disease					Sumi Kitahara (SK)		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Autoimmune lymphoproliferative syndrome	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Indolent T-lymphoblastic proliferation	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
T-lymphoblastic leukaemia / lymphoma, NOS	Disease					HD		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Early T-precursor lymphoblastic leukaemia / lymphoma	Disease	PENDING				HD		Early T-Cell Precursor Lymphoblastic Leukemia	Fei Yang, MD, FACMG, Kaiser Permanente Northwest	Pending
T-prolymphocytic leukaemia	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
T-large granular lymphocytic leukaemia	Disease	PENDING				SK		T-cell Large Granular Lymphocytic Leukemia	Michelle Don, MD, MS	Pending
NK-large granular lymphocytic leukaemia	Disease	PENDING				SK		Chronic Lymphoproliferative Disorder of NK Cells	Michelle Don, MD	Pending
Adult T-cell leukaemia/lymphoma	Disease	PENDING				SK		Adult T-cell Leukemia/Lymphoma	Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center	?Pending
Sezary syndrome	Disease	PENDING				SK		Sézary Syndrome	Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina	Pending
Aggressive NK-cell leukaemia	Disease	PENDING				SK		Aggressive NK-cell Leukemia	Shanelle De Lancy, MD, Shashirekha Shetty, PhD	?Pending
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Mycosis fungoides	Disease	PENDING				SK		Mycosis Fungoides	Jane Scribner, MD and Daynna J. Wolff, PhD	Pending
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma	Disease	PENDING				SK		Primary Cutaneous Anaplastic Large Cell Lymphoma	Theresa Spivey, MD, Shashirekha Shetty, PhD	Pending
Subcutaneous panniculitis-like T-cell lymphoma	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Primary cutaneous gamma/delta T-cell lymphoma	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Primary cutaneous peripheral T-cell lymphoma, NOS	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Indolent T-cell lymphoma of the gastrointestinal tract	Disease	PENDING				SK		Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD	Pending
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Enteropathy-associated T-cell lymphoma	Disease	PENDING				SK		Enteropathy-Associated T-cell Lymphoma	Derick Okwan-Duodu, MD, PhD Sumire Kitahara, MD	Complete	1/21/2021
Monomorphic epitheliotropic intestinal T-cell lymphoma	Disease	PENDING				SK		Monomorphic Epitheliotropic Intestinal T-cell Lymphoma	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD	Pending
Intestinal T-cell lymphoma, NOS	Disease	PENDING				SK		Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)	Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)	Complete	9/26/2022
Hepatosplenic T-cell lymphoma	Disease	PENDING				SK		Hepatosplenic T-cell Lymphoma	Michelle Don, MD, MS	Complete	1/21/2021
ALK-positive anaplastic large cell lymphoma	Disease	PENDING				SK		Anaplastic Large Cell Lymphoma, ALK-Positive	Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA	Complete	09/23/2022
ALK-negative anaplastic large cell lymphoma	Disease	PENDING				SK		Anaplastic Large Cell Lymphoma, ALK-Negative	Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA	Complete	09/23/2022
Breast implant-associated anaplastic large cell lymphoma	Disease	PENDING				SK		Breast Implant-Associated Anaplastic Large Cell Lymphoma	Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center	Pending
Nodal TFH cell lymphoma, angioimmunoblastic-type	Disease	Issue - Rachel Burnside was working on this. Note says: "has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)". Where is her content as previous author names on 5th edition page	7/28/2023	Pending		SK		Angioimmunoblastic T-cell Lymphoma	Sara Akhavanfard, M.D., Ph.D. and Ruthann Pfau, Ph.D., FACMG	Pending
Nodal TFH cell lymphoma, follicular-type	Disease	Rachel Burnside	7/28/2023	Pending		SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Nodal TFH cell lymphoma, NOS	Disease	PENDING				SK		Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype	Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD	Pending
Peripheral T-cell lymphoma, NOS	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
EBV-positive nodal T- and NK-cell lymphoma	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Extranodal NK/T-cell lymphoma	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Severe mosquito bite allergy	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Hydroa vacciniforme lymphoproliferative disorder	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Systemic chronic active EBV disease	Disease					SK		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Systemic EBV-positive T-cell lymphoma of childhood	Disease	PENDING				SK		Systemic EBV-Positive T-cell Lymphoma of Childhood	Lisa A. Lansdon, PhD and Linda D. Cooley, MD, MBA	Complete	11/21/2021
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)
Follicular dendritic cell sarcoma	Disease	PENDING				GC		Follicular Dendritic Cell Sarcoma	Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG	?Pending
EBV-positive inflammatory follicular dendritic cell sarcoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Fibroblastic reticular cell tumour	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Intranodal palisaded myofibroblastoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Littoral cell angioma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Splenic hamartoma	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Sclerosing angiomatoid nodular transformation (SANT) of spleen	Disease					GC		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
CHAPTER 7 (GENETIC TUMOUR SYNDROMES)
Fanconi anaemia	Disease					NA		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Bloom syndrome	Disease					NA		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Ataxia-telangiectasia syndrome	Disease					NA		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
RASopathies	Disease					NA		NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)

Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"

Revision as of 23:54, 23 December 2023

Navigation menu

Search

@@ Line 62: / Line 62: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Chronic myeloid leukaemia|Chronic myeloid leukaemia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Chronic myeloid leukaemia|Chronic myeloid leukaemia]]||Disease||PENDING|| || || || ||FQR|| ||
 |Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
 |Jack Reid, MD (University of California, Irvine)  Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)
@@ Line 69: / Line 69: @@
 |
 |-
-|[[HAEM5:Chronic neutrophilic leukaemia|Chronic neutrophilic leukaemia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Chronic neutrophilic leukaemia|Chronic neutrophilic leukaemia]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Chronic Neutrophilic Leukemia (CNL)
 |Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine  <nowiki>**</nowiki>contributed equally
@@ Line 76: / Line 77: @@
 |
 |-
-|[[HAEM5:Chronic eosinophilic leukaemia|Chronic eosinophilic leukaemia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Chronic eosinophilic leukaemia|Chronic eosinophilic leukaemia]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Chronic Eosinophilic Leukemia, Not Otherwise Specified
 |Chelsea D. Kramish; Daynna J.Wolff
@@ Line 83: / Line 85: @@
 |
 |-
-|[[HAEM5:Polycythaemia vera|Polycythaemia vera]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Polycythaemia vera|Polycythaemia vera]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Polycythemia Vera (PV)
 |Gokce A. Toruner, MD, PhD  UT MD Anderson Cancer Center
@@ Line 90: / Line 93: @@
 |
 |-
-|[[HAEM5:Essential thrombocythaemia|Essential thrombocythaemia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Essential thrombocythaemia|Essential thrombocythaemia]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Essential Thrombocythemia (ET)
 |Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN
@@ Line 97: / Line 101: @@
 |
 |-
-|[[HAEM5:Primary myelofibrosis|Primary myelofibrosis]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Primary myelofibrosis|Primary myelofibrosis]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Primary Myelofibrosis (PMF)
 |T. Niroshi Senaratne, UCLA
@@ Line 104: / Line 109: @@
 |
 |-
-|[[HAEM5:Juvenile myelomonocytic leukaemia|Juvenile myelomonocytic leukaemia]]||Disease|| '''Sarah Rapisardo, PhD, FACMG''' | || || || || ||FQR|| ||
+|[[HAEM5:Juvenile myelomonocytic leukaemia|Juvenile myelomonocytic leukaemia]]||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |PENDING
+| || || || ||FQR|| ||
 |Juvenile Myelomonocytic Leukemia (JMML)
 |<nowiki>Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology</nowiki>
@@ Line 115: / Line 121: @@
 |FQR has emailed SR several times, last 4/20/22
 |-
-|[[HAEM5:Myeloproliferative neoplasm, NOS|Myeloproliferative neoplasm, NOS]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myeloproliferative neoplasm, NOS|Myeloproliferative neoplasm, NOS]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Myeloproliferative Neoplasm (MPN), Unclassifiable
 |Thomas Lee, MD, PhD, University of California, Los Angeles
@@ Line 122: / Line 129: @@
 |
 |-
-|[[HAEM5:Cutaneous mastocytosis|Cutaneous mastocytosis]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Cutaneous mastocytosis|Cutaneous mastocytosis]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Cutaneous Mastocytosis
 |S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD
@@ Line 129: / Line 137: @@
 |
 |-
-|[[HAEM5:Systemic mastocytosis|Systemic mastocytosis]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Systemic mastocytosis|Systemic mastocytosis]]||Disease||PENDING|| || || || ||FQR|| ||
 |Systemic Mastocytosis
 |'''Abdullah Osme, MD,''' University Hospitals Cleveland Medical Center, Case Western Reserve University  '''Shashi Shetty, Ph.D. FACMG, FCCMG,''' University Hospitals Cleveland Medical Center, Case Western Reserve University
@@ Line 136: / Line 144: @@
 |
 |-
-|[[HAEM5:Mast cell sarcoma|Mast cell sarcoma]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Mast cell sarcoma|Mast cell sarcoma]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Mast Cell Sarcoma
 |Jordan Lowery, MD and Thuy Phung, MD, PhD   Department of Pathology, University of South Alabama, Mobile, AL
@@ Line 143: / Line 152: @@
 |
 |-
-|[[HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion|Myelodysplastic neoplasm with low blasts and 5q deletion]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion|Myelodysplastic neoplasm with low blasts and 5q deletion]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Myelodysplastic Syndrome (MDS) with Isolated del(5q)
 |Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG
@@ Line 150: / Line 160: @@
 |
 |-
-|[[HAEM5:Myelodysplastic neoplasm with low blasts and SF3B1 mutation|Myelodysplastic neoplasm with low blasts and SF3B1 mutation]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic neoplasm with low blasts and SF3B1 mutation|Myelodysplastic neoplasm with low blasts and SF3B1 mutation]]||Disease||PENDING
+| || || || ||FQR|| ||
 |NEW (No Prior)
 |NEW (No Prior)
@@ Line 178: / Line 189: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Myelodysplastic neoplasm with increased blasts|Myelodysplastic neoplasm with increased blasts]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic neoplasm with increased blasts|Myelodysplastic neoplasm with increased blasts]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Myelodysplastic Syndrome (MDS) with Excess Blasts
 |Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG  Division of Human Genetics, Cincinnati Children's Hospital Medical Center
@@ Line 185: / Line 197: @@
 |
 |-
-|[[HAEM5:Childhood myelodysplastic neoplasm with low blasts|Childhood myelodysplastic neoplasm with low blasts]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Childhood myelodysplastic neoplasm with low blasts|Childhood myelodysplastic neoplasm with low blasts]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Refractory Cytopenia of Childhood
 |Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG  Division of Human Genetics, Cincinnati Children's Hospital Medical Center
@@ Line 192: / Line 205: @@
 |
 |-
-|[[HAEM5:Childhood myelodysplastic neoplasm with increased blasts|Childhood myelodysplastic neoplasm with increased blasts]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Childhood myelodysplastic neoplasm with increased blasts|Childhood myelodysplastic neoplasm with increased blasts]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Refractory Cytopenia of Childhood
 |Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG  Division of Human Genetics, Cincinnati Children's Hospital Medical Center
@@ Line 199: / Line 213: @@
 |
 |-
-|[[HAEM5:Chronic myelomonocytic leukaemia|Chronic myelomonocytic leukaemia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Chronic myelomonocytic leukaemia|Chronic myelomonocytic leukaemia]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Chronic Myelomonocytic Leukemia (CMML)
 |Linsheng Zhang, MD, PhD
@@ Line 206: / Line 221: @@
 |
 |-
-|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia|Myelodysplastic/myeloproliferative neoplasm with neutrophilia]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia|Myelodysplastic/myeloproliferative neoplasm with neutrophilia]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative
 |Linsheng Zhang, MD, PhD
@@ Line 213: / Line 229: @@
 |
 |-
-|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis|Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis|Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
 |Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine
@@ Line 220: / Line 237: @@
 |
 |-
-|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm, NOS|Myelodysplastic/myeloproliferative neoplasm, NOS]]||Disease|| || || || || ||FQR|| ||
+|[[HAEM5:Myelodysplastic/myeloproliferative neoplasm, NOS|Myelodysplastic/myeloproliferative neoplasm, NOS]]||Disease||PENDING
+| || || || ||FQR|| ||
 |Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable
 |Ruth MacKinnon PhD  Victorian Cancer Cytogenetics Service  Melbourne, Australia
@@ Line 229: / Line 247: @@
 |[[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion|Acute promyelocytic leukaemia with PML::RARA fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 245: / Line 263: @@
 |[[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 261: / Line 279: @@
 |[[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|Acute myeloid leukaemia with CBFB::MYH11 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 277: / Line 295: @@
 |[[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|Acute myeloid leukaemia with DEK::NUP214 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 293: / Line 311: @@
 |[[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|Acute myeloid leukaemia with RBM15::MRTFA fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 309: / Line 327: @@
 |[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|Acute myeloid leukaemia with BCR::ABL1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 325: / Line 343: @@
 |[[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|Acute myeloid leukaemia with KMT2A rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 341: / Line 359: @@
 |[[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|Acute myeloid leukaemia with MECOM rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 373: / Line 391: @@
 |[[HAEM5:Acute myeloid leukaemia with NPM1 mutation|Acute myeloid leukaemia with NPM1 mutation]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 389: / Line 407: @@
 |[[HAEM5:Acute myeloid leukaemia with CEBPA mutation|Acute myeloid leukaemia with CEBPA mutation]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 405: / Line 423: @@
 |[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|Acute myeloid leukaemia, myelodysplasia-related]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 437: / Line 455: @@
 |[[HAEM5:Acute myeloid leukaemia with minimal differentiation|Acute myeloid leukaemia with minimal differentiation]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 453: / Line 471: @@
 |[[HAEM5:Acute myeloid leukaemia without maturation|Acute myeloid leukaemia without maturation]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 469: / Line 487: @@
 |[[HAEM5:Acute myeloid leukaemia with maturation|Acute myeloid leukaemia with maturation]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 485: / Line 503: @@
 |[[HAEM5:Acute basophilic leukaemia|Acute basophilic leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 501: / Line 519: @@
 |[[HAEM5:Acute myelomonocytic leukaemia|Acute myelomonocytic leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 517: / Line 535: @@
 |[[HAEM5:Acute monocytic leukaemia|Acute monocytic leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 533: / Line 551: @@
 |[[HAEM5:Acute erythroid leukaemia|Acute erythroid leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 549: / Line 567: @@
 |[[HAEM5:Acute megakaryoblastic leukaemia|Acute megakaryoblastic leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 565: / Line 583: @@
 |[[HAEM5:Myeloid sarcoma|Myeloid sarcoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 600: / Line 618: @@
 |[[HAEM5:Myeloid neoplasm post cytotoxic therapy|Myeloid neoplasm post cytotoxic therapy]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 616: / Line 634: @@
 |[[HAEM5:Myeloid neoplasms associated with germline predisposition|Myeloid neoplasms associated with germline predisposition]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 632: / Line 650: @@
 |[[HAEM5:Myeloid proliferations associated with Down syndrome|Myeloid proliferations associated with Down syndrome]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 648: / Line 666: @@
 |[[HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement|Myeloid/lymphoid neoplasm with PDGFRA rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 664: / Line 682: @@
 |[[HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement|Myeloid/lymphoid neoplasm with PDGFRB rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 680: / Line 698: @@
 |[[HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement|Myeloid/lymphoid neoplasm with FGFR1 rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 763: / Line 781: @@
 |[[HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion|Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 779: / Line 797: @@
 |[[HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement|Mixed-phenotype acute leukaemia with KMT2A rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 811: / Line 829: @@
 |[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 827: / Line 845: @@
 |[[HAEM5:Mixed-phenotype acute leukaemia, T/myeloid|Mixed-phenotype acute leukaemia, T/myeloid]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 843: / Line 861: @@
 |[[HAEM5:Mixed-phenotype acute leukaemia, rare types|Mixed-phenotype acute leukaemia, rare types]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 875: / Line 893: @@
 |[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 937: / Line 955: @@
 |[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm|Blastic plasmacytoid dendritic cell neoplasm]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 953: / Line 971: @@
 |[[HAEM5:Langerhans cell histiocytosis|Langerhans cell histiocytosis]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 969: / Line 987: @@
 |[[HAEM5:Langerhans cell sarcoma|Langerhans cell sarcoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,081: / Line 1,099: @@
 |[[HAEM5:Histiocytic sarcoma|Histiocytic sarcoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,191: / Line 1,209: @@
 |[[HAEM5:KSHV/HHV8-associated multicentric Castleman disease|KSHV/HHV8-associated multicentric Castleman disease]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,207: / Line 1,225: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,223: / Line 1,241: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,239: / Line 1,257: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-lymphoblastic leukaemia/lymphoma with hypodiploidy]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,255: / Line 1,273: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-lymphoblastic leukaemia/lymphoma with iAMP21]]
 |Disease
-|Holli authoring - Complete? Looks like needs more editing of tables
+|Holli Drendel authoring - Complete? Looks like needs more editing of tables
 |
 |
@@ Line 1,271: / Line 1,289: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,287: / Line 1,305: @@
 |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,303: / Line 1,321: @@
 |[[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,319: / Line 1,337: @@
 |[[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,351: / Line 1,369: @@
 |[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,367: / Line 1,385: @@
 |[[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,448: / Line 1,466: @@
 |
 |-
-|[[HAEM5:Monoclonal B-cell lymphocytosis|Monoclonal B-cell lymphocytosis]]||Disease|| || || || || ||Shivani Golem (SG)
+|[[HAEM5:Monoclonal B-cell lymphocytosis|Monoclonal B-cell lymphocytosis]]||Disease||PENDING
+| || || || ||Shivani Golem (SG)
 | ||
 |Monoclonal B-cell Lymphocytosis
@@ Line 1,468: / Line 1,487: @@
 |
 |-
-|[[HAEM5:Hairy cell leukaemia|Hairy cell leukaemia]]||Disease|| || || || || ||SG|| ||
+|[[HAEM5:Hairy cell leukaemia|Hairy cell leukaemia]]||Disease||PENDING
+| || || || ||SG|| ||
 |Hairy Cell Leukemia
 |Snehal Patel, MD, PhD
@@ Line 1,475: / Line 1,495: @@
 |
 |-
-|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| || || || || ||SG|| ||
+|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease||PENDING
+| || || || ||SG|| ||
 |Splenic Marginal Zone Lymphoma
 |Snehal Patel, MD, PhD
@@ Line 1,482: / Line 1,503: @@
 |
 |-
-|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| ||
+|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease||PENDING
+| || || || ||SG|| ||
 |Splenic Diffuse Red Pulp Small B-cell Lymphoma
 |Snehal Patel, MD, PhD
@@ Line 1,491: / Line 1,513: @@
 |[[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|Splenic B-cell lymphoma/leukaemia with prominent nucleoli]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,507: / Line 1,529: @@
 |[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,523: / Line 1,545: @@
 |[[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,557: / Line 1,579: @@
 |[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,573: / Line 1,595: @@
 |[[HAEM5:Paediatric nodal marginal zone lymphoma|Paediatric nodal marginal zone lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,621: / Line 1,643: @@
 |[[HAEM5:Paediatric-type follicular lymphoma|Paediatric-type follicular lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,653: / Line 1,675: @@
 |[[HAEM5:Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle centre lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,669: / Line 1,691: @@
 |[[HAEM5:In situ mantle cell neoplasm|In situ mantle cell neoplasm]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,685: / Line 1,707: @@
 |[[HAEM5:Mantle cell lymphoma|Mantle cell lymphoma]]
 |Disease
-|
+|PENDING
 |
 |
@@ Line 1,731: / Line 1,753: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Diffuse large B-cell lymphoma, NOS|Diffuse large B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Diffuse large B-cell lymphoma, NOS|Diffuse large B-cell lymphoma, NOS]]||Disease||PENDING
+| || || || ||GC|| ||
 |Diffuse Large B-cell Lymphoma, Not Otherwise Specified
 |Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
@@ Line 1,745: / Line 1,768: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements|Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements|Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements]]||Disease||PENDING
+| || || || ||GC|| ||
 |High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
 |Kate Berry, MBBS, BBus (Hons), Pathology Queensland
@@ Line 1,752: / Line 1,776: @@
 |
 |-
-|[[HAEM5:ALK-positive large B-cell lymphoma|ALK-positive large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:ALK-positive large B-cell lymphoma|ALK-positive large B-cell lymphoma]]||Disease||PENDING
+| || || || ||GC|| ||
 |ALK-Positive Large B-cell Lymphoma
 |Manando Nakasaki, MD, PhD (University of California, Irvine)  Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)
@@ Line 1,759: / Line 1,784: @@
 |Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. FQR emailed Manando on 4/12/23
 |-
-|[[HAEM5:Large B-cell lymphoma with IRF4 rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Large B-cell lymphoma with IRF4 rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]||Disease||PENDING
+| || || || ||GC|| ||
 |Large B-cell Lymphoma with IRF4 Rearrangement
 |Afia Hasnain, MBBS, PhD
@@ Line 1,766: / Line 1,792: @@
 |
 |-
-|[[HAEM5:High grade B-cell lymphoma with 11q aberrations|High grade B-cell lymphoma with 11q aberrations]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:High grade B-cell lymphoma with 11q aberrations|High grade B-cell lymphoma with 11q aberrations]]||Disease||PENDING
+| || || || ||GC|| ||
 |Burkitt-Like Lymphoma with 11q Aberration
 |Lauren Shealy, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
@@ Line 1,794: / Line 1,821: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Fibrin-associated large B-cell lymphoma|Fibrin-associated large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||Note: previously a subset DLBCL assoc with chronic inflam
+|[[HAEM5:Fibrin-associated large B-cell lymphoma|Fibrin-associated large B-cell lymphoma]]||Disease||PENDING
+| || || || ||GC|| ||Note: previously a subset DLBCL assoc with chronic inflam
 |Originally called Fibrin-Associated Diffuse Large B-cell Lymphoma; NEW (No Prior)
 |NEW (No Prior)
@@ Line 1,808: / Line 1,836: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Plasmablastic lymphoma|Plasmablastic lymphoma]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Plasmablastic lymphoma|Plasmablastic lymphoma]]||Disease||PENDING
+| || || || ||GC|| ||
 |Plasmablastic Lymphoma
 |Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)
@@ Line 1,815: / Line 1,844: @@
 |
 |-
-|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease||PENDING
+| || || || ||GC|| ||
 |(1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS
 |(1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital
@@ Line 1,829: / Line 1,859: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:Intravascular large B-cell lymphoma|Intravascular large B-cell lymphoma]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:Intravascular large B-cell lymphoma|Intravascular large B-cell lymphoma]]||Disease||PENDING
+| || || || ||GC|| ||
 |Intravascular Large B-cell Lymphoma
 |Kate Berry, MBBS, BBus (Hons), Pathology Queensland, Greg Corboy
@@ Line 1,850: / Line 1,881: @@
 |NEW (No Prior)
 |-
-|[[HAEM5:High-grade B-cell lymphoma, NOS|High-grade B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| ||
+|[[HAEM5:High-grade B-cell lymphoma, NOS|High-grade B-cell lymphoma, NOS]]||Disease||PENDING
+| || || || ||GC|| ||
 |High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)
 |Aiko Otsubo, PhD, Indiana University, Holli Drendel
@@ Line 1,857: / Line 1,889: @@
 |
 |-
-|Burkitt lymphoma||Disease|| || || || || ||GC|| ||
+|Burkitt lymphoma||Disease||PENDING
+| || || || ||GC|| ||
 |Burkitt Lymphoma
 |Becky Leung, MBBS (Hons), BSc, Pathology Queensland
@@ Line 1,922: / Line 1,955: @@
 |
 |-
-|Classic Hodgkin lymphoma||Disease|| || || || ||Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma
+|Classic Hodgkin lymphoma||Disease||PENDING
+| || || ||Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma
 |GC|| ||
 |(1) Lymphocyte-Rich Classic Hodgkin Lymphoma + (2) Nodular Sclerosis Classic Hodgkin Lymphoma + (3) Mixed Cellularity Classic Hodgkin Lymphoma + (4) Lymphocyte-Depleted Classic Hodgkin Lymphoma
@@ Line 1,975: / Line 2,009: @@
 |NEW (No Prior)
 |-
-|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
+|Immunoglobulin-related (AL) amyloidosis||Disease||PENDING
+| || || || ||SG
 | ||
 |Primary Amyloidosis
@@ Line 1,983: / Line 2,018: @@
 |
 |-
-|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
+|Monoclonal immunoglobulin deposition disease||Disease||PENDING
+| || || || ||SG
 | ||
 |Light Chain and Heavy Chain Deposition Disease
@@ Line 1,999: / Line 2,035: @@
 |NEW (No Prior)
 |-
-|Gamma heavy chain disease||Disease|| || || || || ||SG
+|Gamma heavy chain disease||Disease||PENDING
+| || || || ||SG
 | ||
 |Gamma Heavy Chain Disease
@@ Line 2,015: / Line 2,052: @@
 |NEW (No Prior)
 |-
-|Plasmacytoma||Disease|| || || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
+|Plasmacytoma||Disease||PENDING
+| || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
 |SG
 | ||
@@ Line 2,024: / Line 2,062: @@
 |NEW (No Prior)
 |-
-|Plasma cell myeloma / multiple myeloma||Disease|| || || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
+|Plasma cell myeloma / multiple myeloma||Disease||PENDING
+| || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
 | ||
 |(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants
@@ Line 2,032: / Line 2,071: @@
 |
 |-
-|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease|| || || || ||Note: author needs to include POEMS, TEMPI, and look for AESOP content
+|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||PENDING
+| || || ||Note: author needs to include POEMS, TEMPI, and look for AESOP content
 |SG
 | ||
@@ Line 2,102: / Line 2,142: @@
 |Early T-precursor lymphoblastic leukaemia / lymphoma
 |Disease
-|
+|PENDING
 |
 |
@@ Line 2,132: / Line 2,172: @@
 |NEW (No Prior)
 |-
-|T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
+|T-large granular lymphocytic leukaemia||Disease||PENDING
+| || || || ||SK|| ||
 |T-cell Large Granular Lymphocytic Leukemia
 |Michelle Don, MD, MS
@@ Line 2,139: / Line 2,180: @@
 |
 |-
-|NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
+|NK-large granular lymphocytic leukaemia||Disease||PENDING
+| || || || ||SK|| ||
 |Chronic Lymphoproliferative Disorder of NK Cells
 |Michelle Don, MD
@@ Line 2,146: / Line 2,188: @@
 |
 |-
-|Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| ||
+|Adult T-cell leukaemia/lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Adult T-cell Leukemia/Lymphoma
 |Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG  Vanderbilt University Medical Center
@@ Line 2,153: / Line 2,196: @@
 |
 |-
-|Sezary syndrome||Disease|| || || || || ||SK|| ||
+|Sezary syndrome||Disease||PENDING
+| || || || ||SK|| ||
 |Sézary Syndrome
 |Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
@@ Line 2,160: / Line 2,204: @@
 |
 |-
-|Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| ||
+|Aggressive NK-cell leukaemia||Disease||PENDING
+| || || || ||SK|| ||
 |Aggressive NK-cell Leukemia
 |Shanelle De Lancy, MD, Shashirekha Shetty, PhD
@@ Line 2,181: / Line 2,226: @@
 |NEW (No Prior)
 |-
-|Mycosis fungoides||Disease|| || || || || ||SK|| ||
+|Mycosis fungoides||Disease||PENDING
+| || || || ||SK|| ||
 |Mycosis Fungoides
 |Jane Scribner, MD and Daynna J. Wolff, PhD
@@ Line 2,195: / Line 2,241: @@
 |NEW (No Prior)
 |-
-|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
+|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Primary Cutaneous Anaplastic Large Cell Lymphoma
 |Theresa Spivey, MD, Shashirekha Shetty, PhD
@@ Line 2,230: / Line 2,277: @@
 |NEW (No Prior)
 |-
-|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
+|Indolent T-cell lymphoma of the gastrointestinal tract||Disease||PENDING
+| || || || ||SK|| ||
 |Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
 |Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
@@ Line 2,244: / Line 2,292: @@
 |NEW (No Prior)
 |-
-|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
+|Enteropathy-associated T-cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Enteropathy-Associated T-cell Lymphoma
 |*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
@@ Line 2,251: / Line 2,300: @@
 |
 |-
-|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
+|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
 |Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
@@ Line 2,258: / Line 2,308: @@
 |
 |-
-|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
+|Intestinal T-cell lymphoma, NOS||Disease||PENDING
+| || || || ||SK|| ||
 |Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
 |Derick Okwan MD, PhD (Stanford Medicine, CA)   Sumire Kitahara MD (Cedars-Sinai, CA)
@@ Line 2,265: / Line 2,316: @@
 |
 |-
-|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
+|Hepatosplenic T-cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Hepatosplenic T-cell Lymphoma
 |Michelle Don, MD, MS
@@ Line 2,272: / Line 2,324: @@
 |
 |-
-|ALK-positive anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
+|ALK-positive anaplastic large cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Anaplastic Large Cell Lymphoma, ALK-Positive
 |Miguel Gonzalez Mancera, MD
@@ Line 2,283: / Line 2,336: @@
 |
 |-
-|ALK-negative anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
+|ALK-negative anaplastic large cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Anaplastic Large Cell Lymphoma, ALK-Negative
 |Miguel Gonzalez Mancera, MD  Sumire Kitahara, MD  Cedars-Sinai, Los Angeles, CA
@@ Line 2,290: / Line 2,344: @@
 |
 |-
-|Breast implant-associated anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
+|Breast implant-associated anaplastic large cell lymphoma||Disease||PENDING
+| || || || ||SK|| ||
 |Breast Implant-Associated Anaplastic Large Cell Lymphoma
 |Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD  Cedars-Sinai Medical Center
@@ Line 2,313: / Line 2,368: @@
 |NEW (No Prior)
 |-
-|Nodal TFH cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
+|Nodal TFH cell lymphoma, NOS||Disease||PENDING
+| || || || ||SK|| ||
 |Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype
 |Hans Magne Hamnvåg, MD  Kamran Mirza, MD, PhD
@@ Line 2,362: / Line 2,418: @@
 |NEW (No Prior)
 |-
-|Systemic EBV-positive T-cell lymphoma of childhood||Disease|| || || || || ||SK|| ||
+|Systemic EBV-positive T-cell lymphoma of childhood||Disease||PENDING
+| || || || ||SK|| ||
 |Systemic EBV-Positive T-cell Lymphoma of Childhood
 |Lisa A. Lansdon, PhD and Linda D. Cooley, MD, MBA
@@ Line 2,401: / Line 2,458: @@
 |Follicular dendritic cell sarcoma
 |Disease
-|
+|PENDING
 |
 |